Shanghai SMPA Suspends HEC’s Linagliptin Procurement Over Patent Infringement
The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has revealed that it has suspended the...
Boehringer Ingelheim
Boehringer, Eli Lilly’s Jardiance Wins NMPA Approval for Heart Failure with Preserved Ejection Fraction
Boehringer Ingelheim and Eli Lilly (NYSE: LLY) announced that China’s National Medical Products Administration (NMPA)...
Boehringer Ingelheim Wins Patent Infringement Ruling Against HEC Over Trajenta
The China National Intellectual Property Administration (CNIPA) has ruled in favor of German pharmaceutical giant...
Boehringer Ingelheim Venture Fund and Hong Kong Science Park Launch Co-Incubation Plan
Germany-based pharmaceutical giant Boehringer Ingelheim’s venture fund (BIVF) and China-based Hong Kong Science & Technology...